Top

BMC Complementary Medicine and Therapies

Published in:

Open Access 01-12-2018 | Research article

Zerumbone from Zingiber zerumbet (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium Streptococcus mutans

Authors: Thiago Moreira da Silva, Carlos Danniel Pinheiro, Patricia Puccinelli Orlandi, Carlos Cleomir Pinheiro, Gemilson Soares Pontes

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Abstract

Background

Essential oil obtained from rhizomes of the Zingiber zerumbet (L.) Smith (popularly known in Brazil as bitter ginger) is mainly constituted by the biomolecule zerumbone, which exhibit untapped antimicrobial potential. The aim of this study was to investigate the antimicrobial activity of the zerumbone from bitter ginger rhizomes against the cariogenic agent Streptococcus mutans.

Methods

Firstly, the essential oil from rhizomes of Zingiber zerumbet (L.) Smith extracted by hydrodistillation was submitted to purification and recrystallization process to obtain the zerumbone compound. The purity of zerumbone was determined through high-performance liquid chromatography analysis. Different concentrations of zerumbone were tested against the standard strain S. mutans (ATCC 35668) by using microdilution method. The speed of cidal activity was determined through a time kill-curve assay. The biological cytotoxicity activity of zerumbone was assessed using Vero cell line through MTT assay.

Results

The zerumbone showed a minimum inhibitory concentration (MIC) of 250 μg/mL and a minimum bactericidal concentration (MBC) of 500 μg/mL against S. mutans. After six hours of bacteria-zerumbone interaction, all concentrations tested starts to kill the bacteria and all bacteria were killed between 48 and 72 h period at the concentration of 500 μg/mL (99,99% of bacteria were killed in comparison with original inoculum). In addition, zerumbone showed no cytotoxicity activity on mammalian continuous cells line.

Conclusions

These results draw attention to the potential of zerumbone as antimicrobial agent against S. mutans infection, indicating its possible use in the phyto-pharmaceutical formulations as new approach to prevent and treat tooth decay disease.

Available only for authorised users

Sadaka F. Nguimjeu C. Vroman I, Tighzert L, Couvercelle JP. Review on antimicrobial packaging containing essential oils and their active biomolecules. Innov. Food Sci. Emerg. Technol: Brachais CH; 2014.

Zakaria ZA, Yob NJ, Jofrry SM, MMRMM A, Teh LK, Salleh MZ. Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evidence-based Complement. Altern Med. 2011;2011:1-12

Fakurazi S, Hairuszah I, Mohd Lip J, Shanthi G, Nanthini U, Shamima AR, et al. Hepatoprotective action of zerumbone against paracetamol induced hepatotoxicity. J Med Sci. 2009;9:161–4.CrossRef

Abdel Wahab SI, Abdul AB, Alzubairi AS, Mohamed Elhassan M, Mohan S. In vitro ultramorphological assessment of apoptosis induced by Zerumbone on (HeLa). J Biomed Biotechnol. 2009;2009.

Sulaiman MR, Tengku Mohamad TA, Shaik Mossadeq WM, Moin S, Yusof M, Mokhtar AF, et al. Antinociceptive activity of the essential oil of Zingiber zerumbet. Planta med. 2010;76:107–12. Available from: https://doi.org/10.1055/s-0029-1185950.CrossRef

Somchit MN. Zerumbone isolated from Zingiber zerumbet inhibits inflammation and pain in rats. J Med Plants Res. [Internet]. 2012;6:753–57. Available from: https://doi.org/10.5897/JMPR10.492.

Sidahmed HMA, Hashim NM, Abdulla MA, Ali HM, Mohan S, Abdelwahab SI, et al. Antisecretory, gastroprotective, antioxidant and anti-helicobcter pylori activity of zerumbone from Zingiber zerumbet (L.) smith. PLoS One. 2015;10(3):1–20CrossRef

Baby S, Dan M, Thaha ARM, Johnson AJ, Kurup R, Balakrishnapillaia P, et al. High content of zerumbone in volatile oils of Zingiber zerumbet from southern India and Malaysia. Flavour Fragr J. 2009;24:301–8. Available from: https://doi.org/10.1002/ffj.1940.CrossRef

Rahman HS, Rasedee A, Yeap SK, Othman HH, Chartrand MS, Namvar F, et al. Biomedical properties of a natural dietary plant metabolite, Zerumbone, in cancer therapy and chemoprevention trials. Biomed Res Int. 2014;2014:1–20.

10.

Adbul ABH, Al-Zubairi AS, Tailan ND, Wahab SIA, Zain ZNM, Rusley S, et al. Anticancer activity of natural compound (Zerumbone) extracted from Zingiber zerumbet in human HeLa cervical cancer cells. Int J Pharmacol. 2008;4:160–8.CrossRef

11.

Liu WY, Tzeng T-F, Liu I-M. Healing potential of zerumbone ointment on experimental full-thickness excision cutaneous wounds in rat. J. Tissue Viability, Elsevier Ltd. 2017. p. 6–11. Available from: https://doi.org/10.1016/j.jtv.2017.04.002.CrossRef

12.

Petersen PE. Strengthening of Oral health systems. Oral health through primary health care. Med Princ Pract. 2014;23:1–7. Available from: https://doi.org/10.1159/000356937.CrossRef

13.

Bradshaw DJ, Lynch RJM. Diet and the microbial aetiology of dental caries: new paradigms. Int dent J. 2013;63(Suppl 2):64–72. Available from: https://doi.org/10.1111/idj.12082.CrossRef

14.

Lynch DJ, Michalek SM, Zhu M, Drake D, Qian F, Banas JA. Cariogenicity of Streptococcus mutans glucan-binding protein deletion mutants. Oral Health Dent Manag. [Internet]. 2013;109:191–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24525450.

15.

Baehni PC, Takeuchi Y. Anti-plaque agents in the prevention of biofilm-associated oral diseases. Oral Dis. 2003;9(Suppl 1):23–9.CrossRef

16.

Palombo EA. Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid Based Complement Alternat Med. [Internet]. 2011;2011:680354. Available from: https://doi.org/10.1093/ecam/nep067.CrossRef

17.

Gong HY, Liu WH, GY LV, Zhou X. Analysis of essential oils of Origanum vulgare from six production areas of China and Pakistan. Brazilian J Pharmacogn. 2014;24:25–32.CrossRef

18.

Ben El Hadj Ali I, Chaouachi M, Bahri R, Chaieb I, Boussaïd M, Harzallah-Skhiri F. Chemical composition and antioxidant, antibacterial, allelopathic and insecticidal activities of essential oil of Thymus algeriensis Boiss. et Reut. Ind Crops Prod. 2015;77:631–9. Available from: https://doi.org/10.1016/j.indcrop.2015.09.046.CrossRef

19.

Adams R. Identification of Essential Oil Components by Gas Chromatography / Mass Spectrometry. Identif. Essent. Oil Components by Gas Chromatogr. / Mass Spectrom. 1995;5.

20.

TIB.2033, REV C. Conditions S. Microorganism Maintenance Plan for Laboratories Following ISO 11133. 2014;1–2.

21.

Kumar SN, Lankalapalli RS, Kumar BSD. In vitro antibacterial screening of six proline-based cyclic dipeptides in combination with ??-lactam antibiotics against medically important bacteria. Appl Biochem Biotechnol. 2014;173:116–28.CrossRef

22.

CLSI. M45-A2 Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria ; Approved Guideline — 2nd edn. 2010.

23.

Sutton S. Accuracy of plate counts. J Valid Technol. 2011;17:42–6.

24.

Sartoratto A, Machado ALM, Delarmelina C, Figueira GM, Duarte MCT, Rehder VLG. Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Brazilian J Microbiol. 2004;35:275–80.CrossRef

25.

Friedman PK, Kaufman LB, Karpas SL. Oral health disparity in older adults. Dental decay and tooth loss. Dent Clin North Am. 2014;58(4):757–70.CrossRef

26.

Muts E-J, van Pelt H, Edelhoff D, Krejci I, Cune M. Tooth wear: a systematic review of treatment options. J Prosthet Dent. 2014;112:752–e9. Available from: https://doi.org/10.1016/j.prosdent.2014.01.018.CrossRef

27.

Webster D, Taschereau P, Belland RJ, Sand C, Rennie RP. Antifungal activity of medicinal plant extracts; preliminary screening studies. J Ethnopharmacol. 2008:140–6. Available from: https://doi.org/10.1016/j.jep.2007.09.014.CrossRef

28.

Bagramian RA, Garcia-Godoy F, Volpe AR. The global increase in dental caries. A pending public health crisis. Am. J. Dent. 2009;22:3–8.

29.

Kassebaum NJ, Bernabe E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of untreated caries: a systematic review and metaregression. J Dent Res. 2015;94:650–8. Available from: https://doi.org/10.1177/0022034515573272.CrossRef

30.

Porto TS, Rangel R, Furtado NAJC, De Carvalho TC, Martins CHG, Veneziani RCS, et al. Pimarane-type diterpenes: antimicrobial activity against oral pathogens. Molecules. 2009;14:191–9.CrossRef

31.

Saleem M, Nazir M, Ali MS, Hussain H, Lee YS, Riaz N, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Nat Prod Rep [Internet]. 2010;27:238–54 Available from: https://doi.org/10.1039/B916096E.CrossRef

32.

da Silva JPC, de Castilho AL, Saraceni CHC, Díaz IEC, Paciencia MLB, Suffredini IB. Anti-streptococcal activity of Brazilian Amazon rain Forest plant extracts presents potential for preventive strategies against dental caries. J Appl Oral Sci Rev FOB. 2014;22:91–7.CrossRef

33.

Freire ICM, P??rez ALAL, Cardoso AMR, Mariz BALA, Almeida LFD, Cavalcanti YW, et al. Atividade antibacteriana de ??leos essenciais sobre Streptococcus mutans e Staphylococcus aureus. Rev Bras Plantas Med 2014;16:372–377.CrossRef

34.

Takarada K, Kimizuka R, Takahashi N, Honma K, Okuda K, Kato T. A comparison of the antibacterial efficacies of essential oils against oral pathogens. Oral Microbiol Immunol. 2004;19:61–4.CrossRef

35.

Aguiar GP, Carvalho CE, Dias HJ, Reis EB, Martins MHG, Wakabayashi KAL, et al. Antimicrobial activity of selected essential oils against cariogenic bacteria. Nat Prod Res. 2013;27:1668–72. Available from: https://doi.org/10.1080/14786419.2012.751595.CrossRef

36.

Santosh Kumar SC, Srinivas P, Negi PS, Bettadaiah BK. Antibacterial and antimutagenic activities of novel zerumbone analogues. Food Chem. 2013;141:1097–103.CrossRef

37.

Hasan S, Danisuddin M, Khan AU. Inhibitory effect of Zingiber officinale towards Streptococcus mutans virulence and caries development: in vitro and in vivo studies. BMC Microbiol. 2015;15:1–14. Available from: https://doi.org/10.1186/s12866-014-0320-5.CrossRef

38.

Jones RN, Anderegg TR, Deshpande LM. AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains. Diagn Microbiol Infect Dis. 2002;43:87–90.CrossRef

39.

Anderl JN, Zahller J, Roe F, Stewart PS. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2003;47:1251–6.CrossRef

40.

Gradelski E, Kolek B, Bonner D, Fung-Tomc J. Bactericidal mechanism of gatifloxacin compared with other quinolones. J Antimicrob Chemother. 2002;49:185–8. Available from: http://jac.oxfordjournals.org/content/49/1/185%5C.CrossRef

41.

Nascimento MM, Lemos JA, Abranches J, Lin VK, Burne RA. Role of RelA of Streptococcus mutans in global control of gene expression. J Bacteriol. 2008;190:28–36.CrossRef

42.

Waller SB, Madrid IM, Ferraz V, Picoli T, Cleff MB, de Faria RO, et al. Cytotoxicity and anti-Sporothrix brasiliensis activity of the Origanum majorana Linn. Oil. Brazilian J. Microbiol. 2016;47:896–901.

43.

Lei J, Yu J, Yu H, Liao Z. Composition, cytotoxicity and antimicrobial activity of essential oil from Dictamnus dasycarpus. Food Chem. 2008;107:1205–9.

44.

Fallis A. Manual de toxicologia. J Chem Inf Model. 2013.

Title: Zerumbone from Zingiber zerumbet (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium Streptococcus mutans
Authors: Thiago Moreira da Silva
Carlos Danniel Pinheiro
Patricia Puccinelli Orlandi
Carlos Cleomir Pinheiro
Gemilson Soares Pontes
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI: https://doi.org/10.1186/s12906-018-2360-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Zerumbone from Zingiber zerumbet (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium Streptococcus mutans

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression

A Lanosteryl triterpene from Protorhus longifolia augments insulin signaling in type 1 diabetic rats

The genotoxicity of an aqueous extract of Gyejibokryeong-hwan

Correction to: GLP-I Secretion in Healthy and Diabetic Wistar Rats in Response to Aqueous Extract of Momordica charantia

Artemisia Capillaris leaves inhibit cell proliferation and induce apoptosis in hepatocellular carcinoma

Study on the inhibition of Mfn1 by plant-derived miR5338 mediating the treatment of BPH with rape bee pollen